{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:21:59Z","timestamp":1787318519648,"version":"build-2736575974"},"reference-count":235,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bbadis.2022.166524","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T02:01:54Z","timestamp":1660701714000},"page":"166524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy"],"prefix":"10.1016","volume":"1868","author":[{"given":"Nitesh Kumar","family":"Poddar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamini","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasanandana Supunsiri","family":"Wijayasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunima","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahanavaj","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2022.166524_bb0005","first-page":"1","article-title":"A tale of two signals: AR and WNT in development and tumorigenesis of prostate and mammary gland","author":"Pakula","year":"2017","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.bbadis.2022.166524_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0015","first-page":"7","article-title":"Cancer statistics 2021","volume":"71","author":"Siegel","year":"2021"},{"issue":"13","key":"10.1016\/j.bbadis.2022.166524_bb0020","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.7314\/APJCP.2015.16.13.5137","article-title":"Epidemiology of prostate cancer","volume":"16","author":"Bashir","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0025","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbamcr.2016.02.016","article-title":"The molecular and cellular origin of human prostate cancer","volume":"1863","author":"Packer","year":"2016","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbadis.2022.166524_bb0035","unstructured":"https:\/\/en.gaonconnection.com\/world-alzheimers-day-dementia-mental-world-health-organization-india-asia-africa\/ World Alzheimer's Day: The debilitating affliction is a major public health concern as the world ages 21-Sept-2021."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"17","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JAD-190839","article-title":"Inverse relationship between Alzheimer's disease and cancer: how immune checkpoints might explain the mechanisms underlying age-related diseases","volume":"73","author":"Rogers","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.bbadis.2022.166524_bb0050","doi-asserted-by":"crossref","first-page":"7616","DOI":"10.18632\/oncotarget.24139","article-title":"Alzheimer's disease is associated with prostate cancer: a population-based study","volume":"9","author":"Lin","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/156720509788486608","article-title":"A common biological mechanism in cancer and alzheimers disease?","volume":"6","author":"Behrens","year":"2009","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cll.2020.02.002","article-title":"Clinical bioinformatics in precise diagnosis of mitochondrial disease","volume":"40","author":"Shen","year":"2020","journal-title":"Clin. Lab. Med."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0065","first-page":"1","article-title":"Bioinformatics methods for identifying candidate disease genes","volume":"2","author":"Van Driel","year":"2006","journal-title":"Hum. Genet."},{"issue":"7011","key":"10.1016\/j.bbadis.2022.166524_bb0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature03001","article-title":"Finishing the euchromatic sequence of the human genome","volume":"431","author":"Collins","year":"2004","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0075","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.febslet.2004.12.046","article-title":"Comparison of the current RefSeq, Ensembl and EST databases for counting genes and gene discovery","volume":"579","author":"Larsson","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0080","first-page":"1","article-title":"An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer","volume":"6","author":"Jia","year":"2013","journal-title":"BMC Med. Genet."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/CBM-130363","article-title":"Systems biology of cancer biomarker detection","volume":"13","author":"Mitra","year":"2013","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.bbadis.2022.166524_bb0090","first-page":"1103","article-title":"Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication","volume":"9","author":"He","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0095","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.critrevonc.2015.05.002","article-title":"Potential role of Escherichia coli DNA mismatch repair proteins in colon cancer","volume":"96","author":"Khan","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"13","key":"10.1016\/j.bbadis.2022.166524_bb0100","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1021\/acsomega.9b04042","article-title":"Computational proteome-wide study for the prediction of Escherichia coli protein targeting in host cell organelles and their implication in development of Colon Cancer","volume":"5","author":"Khan","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbadis.2022.166524_bb0105","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/IDR.S258037","article-title":"Analysis of salmonella typhimurium protein-targeting in the nucleus of host cells and the implications in colon cancer: an in-silico approach","volume":"13","author":"Li","year":"2020","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/13685538.2016.1271782","article-title":"Hormone therapy for prostate cancer increases the risk of Alzheimer's disease: a nationwide 4-year longitudinal cohort study","volume":"20","author":"Jhan","year":"2017","journal-title":"Aging Male"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/JU.0000000000001341","article-title":"The risk of new onset dementia and\/or Alzheimer disease among patients with prostate cancer treated with sandrogen deprivation therapy: a systematic review and meta-analysis","volume":"205","author":"Reza","year":"2021","journal-title":"J. Urol."},{"issue":"19","key":"10.1016\/j.bbadis.2022.166524_bb0120","doi-asserted-by":"crossref","first-page":"30830","DOI":"10.18632\/oncotarget.8306","article-title":"Prediction of mycoplasma hominis proteins targeting in mitochondria and cytoplasm of host cells and their implication in prostate cancer etiology","volume":"8","author":"Khan","year":"2017","journal-title":"Oncotarget."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0125","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/molecules23050994","article-title":"To decipher the mycoplasma hominis proteins targeting into the endoplasmic reticulum and their implications in prostate cancer etiology using next-generation sequencing data","volume":"23","author":"Zakariah","year":"2018","journal-title":"Molecules."},{"issue":"33","key":"10.1016\/j.bbadis.2022.166524_bb0130","doi-asserted-by":"crossref","first-page":"54051","DOI":"10.18632\/oncotarget.9912","article-title":"Prostate cancer and the unfolded protein response","volume":"7","author":"Storm","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbadis.2022.166524_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-6-41","article-title":"ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology","volume":"6","author":"Salminen","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbadis.2022.166524_bb0140","first-page":"246","article-title":"Microbial infections are a risk factor for neurodegenerative diseases","author":"Lotz","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2022.166524_bb0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fcimb.2017.00276","article-title":"Neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit","volume":"7","author":"Tohidpour","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0150","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","article-title":"Infectious agents and neurodegeneration","volume":"46","author":"De Chiara","year":"2012","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ab.2009.07.046","article-title":"A top-down approach to enhance the power of predicting human protein subcellular localization: Hum-mPLoc 2.0","volume":"394","author":"Shen","year":"2009","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148530","article-title":"Systems biology approaches for the prediction of possible role of chlamydia pneumoniae proteins in the etiology of lung cancer","volume":"11","author":"Khan","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbadis.2022.166524_bb0165","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1007\/s13277-016-4970-9","article-title":"Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology","volume":"37","author":"Khan","year":"2016","journal-title":"Tumour Biol."},{"issue":"23","key":"10.1016\/j.bbadis.2022.166524_bb0170","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.7150\/jca.63517","article-title":"Decipher the Helicobacter pylori protein targeting in the nucleus of host cell and their implications in gallbladder cancer: an insilico approach","volume":"12","author":"Wang","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.32604\/biocell.2022.016509","article-title":"Proteome-wide screening for the analysis of protein targeting of Chlamydia pneumoniae in endoplasmic reticulum of host cells and their possible implication in lung cancer development","volume":"46","author":"Li","year":"2022","journal-title":"Biocell"},{"issue":"10","key":"10.1016\/j.bbadis.2022.166524_bb0180","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026619666190412121811","article-title":"ABC transporters in neurological disorders: an important gateway for botanical compounds mediated neuro-therapeutics","volume":"19","author":"Jha","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-021-00645-x","article-title":"ADP\/ATP translocase 1 protects against an \u03b1-synuclein-associated neuronal cell damage in Parkinson's disease model","volume":"11","author":"Ding","year":"2021","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13760-016-0666-6","article-title":"Glucose-6-phosphate dehydrogenase a novel hope on a blood-based diagnosis of Alzheimer\u2019s disease","volume":"117","author":"Evlice","year":"2017","journal-title":"Acta Neurol. Belg."},{"issue":"7","key":"10.1016\/j.bbadis.2022.166524_bb0195","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neurobiolaging.2006.05.022","article-title":"Phospholipase D1 is associated with amyloid precursor protein in Alzheimer's disease","volume":"28","author":"Jin","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2022.166524_bb0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer's disease","volume":"12","author":"Hernandez","year":"2018","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.bbadis.2022.166524_bb0205","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.1007\/s12035-019-1591-5","article-title":"Biological hallmarks of cancer in Alzheimer's disease","volume":"56","author":"Nudelman","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","article-title":"The pathogenesis of senile plaques","volume":"56","author":"Dickson","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5580","key":"10.1016\/j.bbadis.2022.166524_bb0215","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"Simi","year":"2016","journal-title":"Biomolecules"},{"issue":"13 B","key":"10.1016\/j.bbadis.2022.166524_bb0225","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/j.1460-2075.1985.tb04132.x","article-title":"Image reconstruction of the Alzheimer paired helical filament","volume":"4","author":"Crowther","year":"1985","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0230","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2022.166524_bb0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"14","key":"10.1016\/j.bbadis.2022.166524_bb0240","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1158\/0008-5472.CAN-14-3297","article-title":"Androgen-induced TMPRSS2 activates matriptase and promotes extracellular matrix degradation, prostate cancer cell invasion, tumor growth, and metastasis","volume":"75","author":"Ko","year":"2015","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbadis.2022.166524_bb0245","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-13-1010","article-title":"The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis","volume":"4","author":"Lucas","year":"2014","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0250","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ng0509-509","article-title":"TMPRSS2-ERG and PTEN loss in prostate cancer","volume":"41","author":"Squire","year":"2009","journal-title":"Nat. Genet."},{"issue":"7267","key":"10.1016\/j.bbadis.2022.166524_bb0255","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.bbadis.2022.166524_bb0260","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.bbadis.2022.166524_bb0265","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/ani10071194","article-title":"Alzheimer's disease, and breast and prostate cancer research: translational failures and the importance to monitor outputs and impact of funded research","volume":"10","author":"Pistollato","year":"2020","journal-title":"Animals (Basel)"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.prnil.2016.09.002","article-title":"Prostate cancer screening with prostate-specific antigen: a guide to the guidelines","volume":"4","author":"Cabarkapa","year":"2016","journal-title":"Prostate Int."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0275","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1258\/acb.2009.009130","article-title":"CSF levels of PSA and PSA\u2013ACT complexes in Alzheimer's disease","volume":"46","author":"Mulder","year":"2009","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbadis.2022.166524_bb0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12935-022-02572-4","article-title":"Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases","volume":"22","author":"Jin","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.10414","article-title":"Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment","volume":"53","author":"DeKosky","year":"2003","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.bbadis.2022.166524_bb0290","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00018-019-03428-3","article-title":"Molecular crosstalk between cancer and neurodegenerative diseases","volume":"77","author":"Seo","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0295","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cbf.1478","article-title":"Vimentin affects the mobility and invasiveness of prostate cancer cells","volume":"26","author":"Zhao","year":"2008","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bbadis.2022.166524_bb0300","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3389\/fnins.2018.01017","article-title":"Tau and mTOR: the hotspots for multifarious diseases in Alzheimer\u2019s development","volume":"13","author":"Mueed","year":"2019","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0305","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ijc.23117","article-title":"2-Methoxyestradiol modulates \u03b2-catenin in prostate cancer cells: a possible mediator of 2-methoxyestradiol-induced inhibition of cell growth","volume":"122","author":"Van Veldhuizen","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105951","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives","volume":"55","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0315","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41391-020-0262-y","article-title":"Crosstalk between COVID-19 and prostate cancer","volume":"23","author":"Bahmad","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0320","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12035-020-02177-w","article-title":"Neurobiochemical cross-talk between COVID-19 and Alzheimer\u2019s disease","volume":"58","author":"Rahman","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.bbadis.2022.166524_bb0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/FPC.0000000000000436","article-title":"ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19","volume":"31","author":"M\u00f6hlendick","year":"2021","journal-title":"Pharmacogenet. Genomics"},{"issue":"8","key":"10.1016\/j.bbadis.2022.166524_bb0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00702-015-1368-6","article-title":"Angiotensin-converting enzyme gene insertion-deletion polymorphism is a risk marker for Alzheimer's disease in a Chinese population: a meta-analysis of case-control studies","volume":"122","author":"Yuan","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0335","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/s12032-011-0051-5","article-title":"Angiotensin-converting enzyme insertion\/deletion polymorphism and the risk of prostate cancer in the Han population of China","volume":"29","author":"Wang","year":"2012","journal-title":"Med. Oncol."},{"issue":"21","key":"10.1016\/j.bbadis.2022.166524_bb0340","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Jian","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"33","key":"10.1016\/j.bbadis.2022.166524_bb0345","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.2174\/1381612826666201118111151","article-title":"Natural products: a rich source of antiviral drug lead candidates for the management of COVID-19","volume":"27","author":"Wijayasinghe","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbadis.2022.166524_bb0350","first-page":"1","article-title":"The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells","author":"Bevan","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10096-020-04138-6","article-title":"COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","volume":"40","author":"Beyerstedt","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bbadis.2022.166524_bb0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/jpm12010029","article-title":"Can SARS-CoV-2 infection exacerbate Alzheimer\u2019s disease? An overview of shared risk factors and pathogenetic mechanisms","volume":"12","author":"Villa","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bbadis.2022.166524_bb0365","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2021.03.100","article-title":"SARS-CoV-2 spike protein interactions with amyloidogenic proteins: potential clues to neurodegeneration","volume":"554","author":"Idrees","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2022.166524_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106414","article-title":"Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer\u2019s disease in COVID-19 patients","volume":"201","author":"Wang","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0375","first-page":"457","article-title":"Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells","volume":"5","author":"Sells","year":"1994","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bbadis.2022.166524_bb0380","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/j.1939-4640.1992.tb00337.x","article-title":"Androgen regulation of programmed death of normal and malignant prostatic cells","volume":"13","author":"Isaacs","year":"1992","journal-title":"J. Androl."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0385","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0303-7207(77)90116-2","article-title":"Methods for estimating the concentration of different forms of androgen receptor in rat ventral prostate","volume":"9","author":"Paul","year":"1977","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pros.2990130204","article-title":"Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death","volume":"13","author":"Connor","year":"1988","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0395","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/1008-682X.179159","article-title":"Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice","volume":"19","author":"Mizokami","year":"2017","journal-title":"Asian J. Androl."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0400","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm972","article-title":"Molecular determinants of resistance to antiandrogen therapy","volume":"10","author":"Chen","year":"2004","journal-title":"Nat. Med."},{"issue":"49","key":"10.1016\/j.bbadis.2022.166524_bb0405","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbadis.2022.166524_bb0410","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/pros.21107","article-title":"Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity","volume":"70","author":"Kawata","year":"2010","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/13685538.2016.1271782","article-title":"Hormone therapy for prostate cancer increases the risk of Alzheimer\u2019s disease: a nationwide 4-year longitudinal cohort study","volume":"20","author":"Jhan","year":"2017","journal-title":"Aging Male"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0420","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","article-title":"Cyclin D1 is a nuclear protein required for cell cycle progression in G1","volume":"7","author":"Baldin","year":"1993","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0425","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1590\/1414-431X20143240","article-title":"Cyclin D1 expression in prostate carcinoma","volume":"47","author":"Pereira","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0430","first-page":"1933","volume":"150","author":"Shupp","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.bbadis.2022.166524_bb0435","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnen\/61.8.678","article-title":"Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex","volume":"61","author":"Hoozemans","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2022.166524_bb0440","series-title":"Urology","first-page":"127","article-title":"The role of cyclooxygenase-2 in prostate cancer","author":"Kirschenbaum","year":"2001"},{"key":"10.1016\/j.bbadis.2022.166524_bb0445","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3389\/fnins.2020.00693","article-title":"Integrated pathways of COX-2 and mTOR: roles in cell sensing and Alzheimer's disease","volume":"0","author":"Tyagi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbadis.2022.166524_bb0450","series-title":"Cellular and Molecular Life Sciences","first-page":"3033","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"Vol. 68","author":"Satelli","year":"2011"},{"issue":"10","key":"10.1016\/j.bbadis.2022.166524_bb0455","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/cells7100147","article-title":"Vimentin diversity in health and disease","volume":"7","author":"Danielsson","year":"2018","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bbadis.2022.166524_bb0460","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/ijms18102079","article-title":"The role and mechanism of epithelial-to-mesenchymal transition in prostate cancer progression","volume":"18","author":"Lo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0465","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/glia.22800","article-title":"GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer\u2019s disease","volume":"63","author":"Kamphuis","year":"2015","journal-title":"Glia."},{"key":"10.1016\/j.bbadis.2022.166524_bb0470","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/RRU.S118966","article-title":"Microtubule-associated protein tau is associated with the resistance to docetaxel in prostate cancer cell lines","volume":"9","author":"Yang","year":"2017","journal-title":"Res. Reports Urol."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0475","first-page":"1891","article-title":"Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone","volume":"6","author":"Drobnjak","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2022.166524_bb0480","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lfs.2016.07.004","article-title":"The hippocampal cyclin D1 expression is involved in postoperative cognitive dysfunction after sevoflurane exposure in aged mice","volume":"160","author":"Fang","year":"2016","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0485","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/pros.10152","article-title":"Cyclooxygenase-2 promotes prostate cancer progression","volume":"53","author":"Fujita","year":"2002","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.bbadis.2022.166524_bb0490","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnen\/61.8.678","article-title":"Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex","volume":"61","author":"Hoozemans","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0495","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1634\/stemcells.2007-1076","article-title":"Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells","volume":"26","author":"Kong","year":"2008","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0500","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neurobiolaging.2004.02.003","article-title":"Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer\u2019s disease: Pro-CAA position statement","volume":"25","author":"Nicoll","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2022.166524_bb0505","first-page":"71","article-title":"Microtubule-associated protein tau is associated with the resistance to docetaxel in prostate cancer cell lines","volume":"9","author":"Yang","year":"2017","journal-title":"Res. Rep. Urol."},{"issue":"s3","key":"10.1016\/j.bbadis.2022.166524_bb0510","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2006-9S321","article-title":"Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease","volume":"9","author":"Brion","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0515","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/mgme.1998.2798","article-title":"Cell signaling defects and human disease","volume":"66","author":"Mora-Garcia","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2022.166524_bb0520","series-title":"iMedPub Journals Wnt Signaling and Epithelial-Mesenchymal Transition Network in Cancer","first-page":"2","author":"Tanabe","year":"2018"},{"issue":"21","key":"10.1016\/j.bbadis.2022.166524_bb0525","first-page":"35376","article-title":"Epithelial-mesenchymal transition in prostate cancer: an overview","volume":"8","author":"Montanari","year":"2017"},{"key":"10.1016\/j.bbadis.2022.166524_bb0530","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fncel.2019.00227","article-title":"Wnt signaling deregulation in the aging and Alzheimer\u2019s brain","volume":"0","author":"Palomer","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0535","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.pcan.4500794","article-title":"Wnt signalling and prostate cancer","volume":"8","author":"Yardy","year":"2005","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0540","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-019-0525-5","article-title":"Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease","volume":"12","author":"Jia","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbadis.2022.166524_bb0545","series-title":"Biochemical Society Transactions. Biochem Soc Trans","first-page":"721","article-title":"Insulin and IGF-1 signalling: Longevity, protein homoeostasis and Alzheimer\u2019s disease","author":"O\u2019Neill","year":"2012"},{"key":"10.1016\/j.bbadis.2022.166524_bb0550","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jcb.20929","article-title":"Interaction of IGF signaling and the androgen receptor in prostate cancer progression","volume":"99","author":"Wu","year":"2006","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0555","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","article-title":"The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases","volume":"35","author":"Ben","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2022.166524_bb0560","series-title":"Current Opinion in Endocrine and Metabolic Research","first-page":"36","article-title":"Cytokines and Janus kinase\/signal transducer and activator of transcription signaling in prostate cancer: overview and therapeutic opportunities","volume":"10","author":"Canesin","year":"2020"},{"issue":"9","key":"10.1016\/j.bbadis.2022.166524_bb0565","first-page":"1129","article-title":"Protein Kinase C-dependent and-independent Pathways of Signal Transduction in Prostate Cancer Cells: Fibroblast Growth Factor Utilization of a Protein Kinase C-independent Pathway","volume":"6","author":"Hrr","year":"1995","journal-title":"Cell Growth Differ."},{"issue":"30","key":"10.1016\/j.bbadis.2022.166524_bb0570","doi-asserted-by":"crossref","first-page":"11141","DOI":"10.1073\/pnas.0403921101","article-title":"Therapeutic effects of PKC activators in Alzheimer\u2019s disease transgenic mice","volume":"101","author":"Etcheberrigaray","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bbadis.2022.166524_bb0575","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/ijc.22862","article-title":"Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion","volume":"121","author":"Shukla","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.bbadis.2022.166524_bb0580","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0585","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.bbadis.2022.166524_bb0590","series-title":"Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging","first-page":"231","article-title":"Mechanistic target of rapamycin: The alpha and omega of autophagy regulation","volume":"Volume 12","author":"McKee-Muir","year":"2017"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56237-w","article-title":"mTORC1 and mTORC2 differentially regulate cell fate programs to coordinate osteoblastic differentiation in mesenchymal stromal cells","volume":"9","author":"Schaub","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2022.166524_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/S1874-6047(10)27002-6","article-title":"Regulation of TOR signaling in mammals","author":"Lamming","year":"2010","journal-title":"Enzymes."},{"issue":"7661","key":"10.1016\/j.bbadis.2022.166524_bb0605","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature22964","article-title":"mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer","volume":"547","author":"Zabala-Letona","year":"2017","journal-title":"Nat"},{"key":"10.1016\/j.bbadis.2022.166524_bb0610","series-title":"Targeted Oncology","first-page":"47","article-title":"mTOR inhibitors in castration-resistant prostate cancer: a systematic review","volume":"Vol. 12","author":"Statz","year":"2017"},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0615","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119015","article-title":"mLST8 promotes mTOR-mediated tumor progression","volume":"10","author":"Kakumoto","year":"2015","journal-title":"PLoS One"},{"issue":"C","key":"10.1016\/j.bbadis.2022.166524_bb0625","first-page":"1","article-title":"TOR complexes: composition, structure, and phosphorylation","volume":"27","author":"Zinzalla","year":"2010","journal-title":"Enzymes"},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0630","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","article-title":"PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase","volume":"25","author":"Sancak","year":"2007","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0635","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor whose frequent overexpression in multiple myeloma cells promotes their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2022.166524_bb0640","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","article-title":"Cell cycle mTOR complex 2 signaling and functions","volume":"10","author":"Oh","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbadis.2022.166524_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/S1874-6047(10)27003-8","article-title":"Rheb G-proteins and the activation of mTORC1","author":"Parmar","year":"2010","journal-title":"Enzymes."},{"issue":"43","key":"10.1016\/j.bbadis.2022.166524_bb0650","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1038\/onc.2008.180","article-title":"Constitutively active Rheb induces oncogenic transformation","volume":"27","author":"Jiang","year":"2008","journal-title":"Oncogene"},{"issue":"55","key":"10.1016\/j.bbadis.2022.166524_bb0655","doi-asserted-by":"crossref","first-page":"ra3","DOI":"10.1126\/scisignal.2000029","article-title":"Characterization of the intrinsic and TSC2-GAP\u2013regulated GTPase activity of Rheb by real-time NMR","volume":"2","author":"Marshall","year":"2009","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0660","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","article-title":"Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2","volume":"11","author":"Garami","year":"2003","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0665","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0670","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncb1547","article-title":"Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40","volume":"9","author":"Vander","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088891","article-title":"The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase","volume":"9","author":"Mori","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-1-3","article-title":"Dysfunction of the mTOR pathway is a risk factor for Alzheimer\u2019s disease","volume":"1","author":"Yates","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0685","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers7030860","article-title":"Signaling pathways in cancer","volume":"7","author":"Regad","year":"2015","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0690","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbrc.2003.09.132","article-title":"Role of PI3K\/AKT\/mTOR signaling in the cell cycle progression of human prostate cancer","volume":"310","author":"Gao","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0695","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2008.12.017","article-title":"mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice","volume":"15","author":"Guertin","year":"2009","journal-title":"Cancer Cell"},{"issue":"5\u20136","key":"10.1016\/j.bbadis.2022.166524_bb0700","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/hsz-2016-0312","article-title":"Rheb in neuronal degeneration, regeneration, and connectivity","volume":"398","author":"Potheraveedu","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2022.166524_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer's disease and Parkinson's disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbadis.2022.166524_bb0710","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1074\/jbc.M113.532713","article-title":"Rheb GTPase regulates \u03b2-secretase levels and amyloid \u03b2 generation","volume":"289","author":"Shahani","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0715","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/cancers5020639","article-title":"Ras and Rheb signaling in survival and cell death","volume":"5","author":"Ehrkamp","year":"2013","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0725","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030755","article-title":"mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy","volume":"20","author":"Tian","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5152\/tjbh.2015.2711","article-title":"Male breast cancer","volume":"12","author":"Yalaza","year":"2016","journal-title":"J. Breast Heal."},{"issue":"18","key":"10.1016\/j.bbadis.2022.166524_bb0735","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.ejca.2008.09.034","article-title":"What is triple-negative breast cancer?","volume":"44","author":"Irvin","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0740","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.breast.2011.09.008","article-title":"mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors","volume":"21","author":"Walsh","year":"2012","journal-title":"Breast"},{"issue":"11","key":"10.1016\/j.bbadis.2022.166524_bb0745","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pros.20410","article-title":"Expression of mTOR signaling pathway markers in prostate cancer progression","volume":"66","author":"Kremer","year":"2006","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0750","first-page":"383","article-title":"mTOR function and therapeutic targeting in breast cancer","volume":"7","author":"Hare","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbadis.2022.166524_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109934","article-title":"mTOR modulates resistance to gemcitabine in lung cancer in an MTORC2 dependent mechanism","volume":"81","author":"Chawsheen","year":"2021","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0760","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CBM-200039","article-title":"TRIP13 promotes lung cancer cell growth and metastasis through AKT\/mTORC1\/c-Myc signaling","volume":"30","author":"Cai","year":"2021","journal-title":"Cancer Biomark."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0765","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/1535-7163.MCT-11-0723","article-title":"Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: therapeutic implications","volume":"11","author":"Montero","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.bbadis.2022.166524_bb0770","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","article-title":"mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways","volume":"71","author":"Gulhati","year":"2011","journal-title":"Cancer Res."},{"issue":"38","key":"10.1016\/j.bbadis.2022.166524_bb0775","doi-asserted-by":"crossref","first-page":"61890","DOI":"10.18632\/oncotarget.11301","article-title":"Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells","volume":"7","author":"Ippolito","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0780","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajur.2018.09.001","article-title":"Combination therapy with androgen deprivation for hormone sensitive prostate cancer: a new frontier","volume":"6","author":"Etheridge","year":"2019","journal-title":"Asian J. Urol."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb0785","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1758834017692779","article-title":"Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting","volume":"9","author":"Puente","year":"2017","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"10","key":"10.1016\/j.bbadis.2022.166524_bb0790","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1158\/1535-7163.MCT-05-0130","article-title":"Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells","volume":"4","author":"Morse","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0795","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2022.166524_bb0800","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.3389\/fonc.2020.584505","article-title":"Endothelial cells promote docetaxel resistance of prostate cancer cells by inducing ERG expression and activating Akt\/mTOR signaling pathway","volume":"10","author":"Zhou","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0805","first-page":"2242","article-title":"Efficacy of gefitinib-celecoxib combination therapy in docetaxel-resistant prostate cancer","volume":"40","author":"Lin","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2022.166524_bb0810","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.2147\/OTT.S153764","article-title":"Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions","volume":"11","author":"Tucci","year":"2018","journal-title":"Onco. Targets. Ther."},{"issue":"312","key":"10.1016\/j.bbadis.2022.166524_bb0815","doi-asserted-by":"crossref","first-page":"312re10","DOI":"10.1126\/scitranslmed.aac9511","article-title":"Plasma AR and abiraterone-resistant prostate cancer","volume":"7","author":"Romanel","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"14","key":"10.1016\/j.bbadis.2022.166524_bb0820","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1158\/1078-0432.CCR-15-2309","article-title":"ErbB2 signaling increases androgen receptor expression in abiraterone-resistant prostate cancer","volume":"22","author":"Gao","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.bbadis.2022.166524_bb0825","first-page":"2506","article-title":"Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer","volume":"381","author":"Wit","year":"2019"},{"issue":"8","key":"10.1016\/j.bbadis.2022.166524_bb0830","first-page":"2887","article-title":"Pharmacodynamic evaluation of CCI-779, an inshibitor of mTOR, in cancer patients","volume":"9","author":"Peralba","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbadis.2022.166524_bb0835","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/0008-5472.CAN-04-3137","article-title":"Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts","volume":"65","author":"Wu","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0840","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11523-016-0453-6","article-title":"mTOR inhibitors in castration-resistant prostate cancer: a systematic review","volume":"12","author":"Statz","year":"2017","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bbadis.2022.166524_bb0845","first-page":"513","volume":"57","author":"Lle\u00f3","year":"2006","journal-title":"Curr. Pharmacother. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbadis.2022.166524_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112075","article-title":"Saponins: extraction, bio-medicinal properties and way forward to anti-viral representatives","volume":"150","author":"Sharma","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbadis.2022.166524_bb0855","series-title":"Functional and Preservative Properties of Phytochemicals","first-page":"341","article-title":"Phytochemicals","author":"Thakur","year":"2020"},{"key":"10.1016\/j.bbadis.2022.166524_bb0860","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s42452-020-2280-8","article-title":"Screening the binding potential of quercetin with parallel, antiparallel and mixed G-quadruplexes of human telomere and cancer protooncogenes using molecular docking approach","volume":"2","author":"Tyagi","year":"2020","journal-title":"SN Appl. Sci."},{"key":"10.1016\/j.bbadis.2022.166524_bb0865","doi-asserted-by":"crossref","first-page":"8152373","DOI":"10.1155\/2018\/8152373","article-title":"Neuroprotective mechanisms of resveratrol in Alzheimer's disease: role of SIRT1","volume":"2018","author":"Gomes","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2022.166524_bb0870","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fnagi.2014.00218","article-title":"Neuroprotective effects of resveratrol in Alzheimer disease pathology","volume":"6","author":"Rege","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbadis.2022.166524_bb0875","first-page":"372","article-title":"Sirtuins as potential therapeutic targets for mitigating neuroinflammation associated with Alzheimer\u2019s disease","author":"Fernando","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0880","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bbadis.2014.10.005","article-title":"The molecular targets of resveratrol","volume":"1852","author":"Kulkarni","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"47","key":"10.1016\/j.bbadis.2022.166524_bb0885","doi-asserted-by":"crossref","first-page":"36387","DOI":"10.1074\/jbc.M110.169284","article-title":"Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR","volume":"285","author":"Liu","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0890","first-page":"1","article-title":"Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition","volume":"6","author":"Park","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2022.166524_bb0895","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","article-title":"The therapeutic potential of resveratrol: a review of clinical trials","volume":"1","author":"Berman","year":"2017","journal-title":"npj Precis. Oncol."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0900","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3390\/molecules24061123","article-title":"Antioxidant activities of quercetin and its complexes for medicinal application","volume":"24","author":"Xu","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0905","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu8030167","article-title":"Quercetin, inflammation and immunity","volume":"8","author":"Li","year":"2016","journal-title":"Nutrients."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0910","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biom10010059","article-title":"Neuroprotective effects of quercetin in Alzheimer's disease","volume":"10","author":"Khan","year":"2019","journal-title":"Biomolecules."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0915","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/13543770902762893","article-title":"Sirtuin activators","volume":"19","author":"Alca\u00edn","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bbadis.2022.166524_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111548","article-title":"Emerging impact of quercetin in the treatment of prostate cancer","volume":"138","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0925","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.3892\/or.2015.3886","article-title":"Quercetin in prostate cancer: chemotherapeutic and chemopreventive effects, mechanisms and clinical application potential (Review)","volume":"33","author":"Yang","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0930","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-018-1400-z","article-title":"Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways","volume":"16","author":"Ward","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.bbadis.2022.166524_bb0935","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biopha.2015.12.013","article-title":"Protective role of epigallocatechin-3-gallate in health and disease: a perspective","volume":"78","author":"Chowdhury","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0940","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/mmr.2016.5277","article-title":"(-)-Epigallocatechin-3-gallate induces apoptosis in human pancreatic cancer cells via PTEN","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166524_bb0945","first-page":"1885","article-title":"PTEN\/AKT\/mTOR signaling mediates anticancer effects of epigallocatechin-3-gallate in ovarian cancer","volume":"43","author":"Qin","year":"2020","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb0950","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2011.02.010","article-title":"Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase\/mTOR inhibitor","volume":"406","author":"Van Aller","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bbadis.2022.166524_bb0955","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1158\/1940-6207.CAPR-08-0167","volume":"2","author":"McLarty","year":"2009","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0960","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0007114515004687","article-title":"Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease","volume":"115","author":"Goozee","year":"2016","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbadis.2022.166524_bb0965","doi-asserted-by":"crossref","first-page":"146476","DOI":"10.1016\/j.brainres.2019.146476","article-title":"The effect of curcumin on cognition in Alzheimer's disease and healthy aging: A systematic review of pre-clinical and clinical studies","volume":"1725","author":"Voulgaropoulou","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2022.166524_bb0970","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejphar.2014.06.051","article-title":"Downregulation of PI3K\/Akt\/mTOR signaling pathway in curcumin-induced autophagy in APP\/PS1 double transgenic mice","volume":"740","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.bbadis.2022.166524_bb0975","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.3390\/ijms21155459","article-title":"A curcumin analog exhibits multiple biologic effects on the pathogenesis of Alzheimer's disease and improves behavior, inflammation, and \u03b2-amyloid accumulation in a mouse model","volume":"21","author":"Su","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2022.166524_bb0980","article-title":"Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more, oxidative medicine and cellular longevity","volume":"2016","author":"Costa","year":"2016","journal-title":"Hindawi Limited"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb0985","first-page":"31","article-title":"Putative role of red wine polyphenols against brain pathology in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"12","author":"Caruana","year":"2016","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb0990","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0003-9861(02)00668-9","article-title":"Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells","volume":"410","author":"Gupta","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb0995","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/01635580801947674","article-title":"Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo","volume":"60","author":"Lee","year":"2008","journal-title":"Nutr. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1000","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phymed.2009.09.011","article-title":"Green tea polyphenols for prostate cancer chemoprevention: a translational perspective","volume":"17","author":"Johnson","year":"2010","journal-title":"Phytomedicine."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb1005","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1096\/fj.10-167924","article-title":"Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer","volume":"25","author":"Siddiqui","year":"2011","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.bbadis.2022.166524_bb1010","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3945\/jn.109.109785","article-title":"Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice","volume":"139","author":"Lee","year":"2009","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jnutbio.2012.06.011","article-title":"Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties","volume":"24","author":"Lee","year":"2013","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yexcr.2015.04.004","article-title":"(-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression","volume":"334","author":"Chang","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.bbadis.2022.166524_bb1025","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/biom10111536","article-title":"Curcumin against prostate cancer: current evidence","volume":"10","author":"Termini","year":"2020","journal-title":"Biomolecules."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb1030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","article-title":"Review: curcumin and Alzheimer's disease","volume":"16","author":"Hamaguchi","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb1035","first-page":"116","article-title":"Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro","volume":"14","author":"Deng","year":"2008","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb1040","first-page":"825","article-title":"Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines","volume":"21","author":"Nakamura","year":"2002","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb1045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.pcan.4500856","article-title":"The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo","volume":"9","author":"Hong","year":"2006","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb1050","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4103\/1673-5374.230303","volume":"13","author":"Chen","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"17","key":"10.1016\/j.bbadis.2022.166524_bb1055","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.bmc.2014.07.009","article-title":"Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer\u2019s disease therapy","volume":"22","author":"Li","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbadis.2022.166524_bb1060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2050-6511-15-59","article-title":"Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells","volume":"15","author":"Chen","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"17","key":"10.1016\/j.bbadis.2022.166524_bb1065","doi-asserted-by":"crossref","first-page":"10254","DOI":"10.1039\/C9RA10020B","article-title":"Nobiletin, a citrus polymethoxyflavone, enhances the effects of bicalutamide on prostate cancer cells via down regulation of NF-\u03baB, STAT3, and ERK activation","volume":"10","author":"Ma","year":"2020","journal-title":"RSC Adv."},{"issue":"14","key":"10.1016\/j.bbadis.2022.166524_bb1070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143380","article-title":"Potential benefits of nobiletin, a citrus flavonoid, against Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"20","author":"Nakajima","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.bbadis.2022.166524_bb1075","doi-asserted-by":"crossref","first-page":"10254","DOI":"10.1039\/C9RA10020B","article-title":"Nobiletin, a citrus polymethoxyflavone, enhances the effects of bicalutamide on prostate cancer cells: Via down regulation of NF-\u03baB, STAT3, and ERK activation","volume":"10","author":"Ma","year":"2020","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166524_bb1080","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11011-022-00932-7","article-title":"Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation","volume":"37","author":"Chai","year":"2022","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.taap.2007.12.027","article-title":"Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation","volume":"229","author":"Meeran","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbadis.2022.166524_bb1090","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1535-7163.MCT-10-0985","article-title":"Berberine suppresses androgen receptor signaling in prostate cancer","volume":"10","author":"Li","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-019-2510-z","article-title":"Neuroprotective effects of berberine in animal models of Alzheimer\u2019s disease: A systematic review of pre-clinical studies","volume":"19","author":"Yuan","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166524_bb1100","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2006.11.043","article-title":"Berberine alters the processing of Alzheimer\u2019s amyloid precursor protein to decrease A\u03b2 secretion","volume":"352","author":"Asai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7150\/ijms.9982","article-title":"Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance","volume":"12","author":"Liu","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbadis.2022.166524_bb1110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1746-1596-9-98","article-title":"Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer","volume":"9","author":"Zhang","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bbadis.2022.166524_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109670","article-title":"Berberine mitigates cognitive decline in an Alzheimer's disease mouse model by targeting both tau hyperphosphorylation and autophagic clearance","volume":"121","author":"Chen","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.bbadis.2022.166524_bb1120","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1021\/acschemneuro.0c00808","article-title":"Berberine improves behavioral and cognitive deficits in a mouse model of Alzheimer's disease via regulation of \u03b2-amyloid production and endoplasmic reticulum stress","volume":"12","author":"Liang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2013.02.032","article-title":"Bioavailability of phytochemicals and its enhancement by drug delivery systems","volume":"334","author":"Aqil","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2022.166524_bb1130","article-title":"Recent developments of nanotechnology for Alzheimer\u2019s disease diagnosis and therapy","volume":"4","author":"Dai","year":"2018","journal-title":"Glob. J. Nanomed. Rev. Artic"},{"key":"10.1016\/j.bbadis.2022.166524_bb1135","doi-asserted-by":"crossref","first-page":"109745","DOI":"10.1016\/j.cbi.2021.109745","article-title":"Promises of phytochemical based nano drug delivery systems in the management of cancer","volume":"351","author":"Kumar","year":"2022","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.bbadis.2022.166524_bb1140","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/jm1013715","article-title":"Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells","volume":"54","author":"Sanna","year":"2011","journal-title":"J. Med. Chem."},{"issue":"1-2","key":"10.1016\/j.bbadis.2022.166524_bb1145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijpharm.2010.01.012","article-title":"Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease","volume":"389","author":"Smith","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbadis.2022.166524_bb1150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biomaterials.2014.12.005","article-title":"Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer\u2019s disease mice using magnetic resonance imaging (MRI)","volume":"44","author":"Cheng","year":"2015","journal-title":"Biomaterials."},{"issue":"1","key":"10.1016\/j.bbadis.2022.166524_bb1155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.maturitas.2012.01.016","article-title":"Nanoparticle therapeutics for prostate cancer treatment","volume":"73","author":"Sanna","year":"2012","journal-title":"Maturitas."},{"issue":"30","key":"10.1016\/j.bbadis.2022.166524_bb1160","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1016\/j.biomaterials.2014.06.040","article-title":"Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer","volume":"35","author":"Yallapu","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bbadis.2022.166524_bb1165","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s12035-013-8401-2","article-title":"Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules","volume":"47","author":"Frozza","year":"2013","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.bbadis.2022.166524_bb1170","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1039\/C5NR08966B","article-title":"Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo","volume":"8","author":"Zhao","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbadis.2022.166524_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101795","article-title":"Neuroprotective effect of quercetin nanoparticles: a possible prophylactic and therapeutic role in alzheimer\u2019s disease","volume":"107","author":"Rifaai","year":"2020","journal-title":"J. Chem. Neuroanat."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922001958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:14:54Z","timestamp":1760418894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443922001958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":235,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0925443922001958"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166524","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166524"}}